Aerovate Therapeutics scoops up $72.6m Series A

Aerovate Therapeutics Inc, a biotech company, has raised $72.6 million in Series A funding.

Aerovate Therapeutics Inc, a biotech company, has raised $72.6 million in Series A funding. Sofinnova Investments led the round with participation from Atlas Venture, Cormorant Asset Management, Surveyor Capital and Osage University Partners. Aerovate was founded and incubated by RA Capital Management.

Source: Press Release